Uniting to Triumph Over COVID-19: Harnessing the Power of Clinical Trials.

Pakistan (Muhammad Yasir)

In the face of the persistent threat posed by COVID-19, our collective resilience shines brighter than ever, stated Dr. Saboora Waris, Associate Director, at Maroof International Hospital.

Today, we come together to underscore three critical facets that demand our unwavering attention and action: the relentless presence of COVID-19, the pivotal role of clinical trials in shaping our defense, and the opportunity for free COVID-19 treatment that empowers us all. Speaking at a Media Roundtable organized by FINN Partners, on “COVID-19 and the importance of clinical trials” she shared that even as we strive for normalcy, the specter of COVID-19 still looms large. This virus has tested our resolve, but it cannot diminish our determination. We must remain vigilant and proactive to safeguard our communities and chart a course toward a brighter future.

Speaking on the worth and significance of clinical trials Dr. Saboora said that our battle against diseases, especially COVID-19, cannot be overstated. These trials serve as crucibles of hope and progress, where life-changing vaccines and groundbreaking medicines are forged. By participating in clinical trials, individuals become not just beneficiaries but champions of medical innovation. Every trial participant plays a pivotal role in the development of treatments and vaccines that can change the course of the pandemic and save lives.

Dr. Waris announced that free COVID-19 tests are readily available at Maroof International Hospital, and several hospitals and testing centers have stepped forward, ensuring that access to testing is not a privilege but a fundamental right. These tests empower us to take control of our health, protect our loved ones, and collectively diminish the virus’s grip on our lives.

The path forward is illuminated by our shared commitment to science, our resolve to protect one another, and our faith in the power of medical innovation. Let us stand united, for in our collective strength, we find the power to reshape the narrative of this pandemic.

Uniting to Triumph Over COVID-19: Harnessing the Power of Clinical Trials

Pakistan (Muhammad Yasir)

In the face of the persistent threat posed by COVID-19, our collective resilience shines brighter than ever, stated Dr. Saboora Waris, Associate Director, at Maroof International Hospital.Today, we come together to underscore three critical facets that demand our unwavering attention and action: the relentless presence of COVID-19, the pivotal role of clinical trials in shaping our defense, and the opportunity for free COVID-19 treatment that empowers us all.

Speaking at a Media Roundtable organized by FINN Partners, on “COVID-19 and the importance of clinical trials” she shared that even as we strive for normalcy, the specter of COVID-19 still looms large. This virus has tested our resolve, but it cannot diminish our determination. We must remain vigilant and proactive to safeguard our communities and chart a course toward a brighter future.

Speaking on the worth and significance of clinical trials Dr. Saboora said that our battle against diseases, especially COVID-19, cannot be overstated. These trials serve as crucibles of hope and progress, where life-changing vaccines and groundbreaking medicines are forged. By participating in clinical trials, individuals become not just beneficiaries but champions of medical innovation. Every trial participant plays a pivotal role in the development of treatments and vaccines that can change the course of the pandemic and save lives.

Dr. Waris announced that free COVID-19 tests are readily available at Maroof International Hospital, and several hospitals and testing centers have stepped forward, ensuring that access to testing is not a privilege but a fundamental right. These tests empower us to take control of our health, protect our loved ones, and collectively diminish the virus’s grip on our lives.

The path forward is illuminated by our shared commitment to science, our resolve to protect one another, and our faith in the power of medical innovation. Let us stand united, for in our collective strength, we find the power to reshape the narrative of this pandemic.

The post Uniting to Triumph Over COVID-19: Harnessing the Power of Clinical Trials appeared first on News Update Times.

Covid-19 has not left says us PROF DR. JAVED AKRAM

Lahore (Muhammad Yasir)

Covid-19 has not left us and we are seeing many cases, with some still suffering symptoms from the last attack, known as Long-Covid……… . This was stated by PROF DR. JAVED AKRAM, of the Akram Medical Complex and Caretaker Provincial Minister for Health & Social Welfare; at the media roundtable, while speaking on “COVID-19 still a public threat and the importance of clinical trials.”

Although COVID-19 cases have reduced, but at its peak it claimed 30,000 plus lives and infected more than 1.58 Million people in Pakistan. WHO has not downgraded the threat of COVID, as many variants are still prevalent in different parts of the world including Pakistan. However, in most countries Clinical Research and Trails have played a major role in finding different medicines and vaccines, which have offered patients and the general public medical cover against the menace of this pandemic. Research and Clinical Trials have also resulted in introduction of medicines which reduce the severity of the disease.

In light of the above, FINN Partners organised a “Media Roundtable” to create awareness among the media and through them in the general public about the importance of clinical trials. Clinical studies are essential for identifying additional approaches to protect our communities against major health threats. The participation of thousands of people in clinical studies was a key factor in the safe and efficient development of vaccines, as studies strictly adhered to international research ethics protocols.

DR MUHAMMAD AHMAD of Central Park Teaching Hospital and a leading Pulmonologist shared his views about the “Impact of clinical trials on a country and the current clinical trials’ misconception.” Dr Ahmad explained.The participants asked several questions from the speakers, who also shared that Akram Medical Complex, Central Park Teaching Hospital and National Hospital & Medical Centre are facilitating the general public by offering free

DR MUHAMMAD AHMAD of Central Park Teaching Hospital and a leading Pulmonologist shared his views about the “Impact of clinical trials on a country and the current clinical trials’ misconception.” He explained that in Pakistan there is a misconception attached with clinical trials and the medicines being tested; one being that the administration of any trial medicine will make the participant impotent. This is just a myth, there are always strict protocols which are to be followed, most of these are standardized by FDA (US Federal Drug Authority) which is a benchmark for all clinical trials supported in many countries’ own rules and procedures e.g. going through different levels of ethics committees.

The participants asked several questions from the speakers, responding to a question Dr Javed Akram explained that thorough research is required to measure the efficacy of any drug according to the climate, food, race and other factors of any particular country. Both the speakers explained different phases of clinical trials. They also informed that Akram Medical Complex, Central Park Teaching Hospital and National Hospital & Medical Centre are facilitating the general public by offering free COVID-19 Tests to those who are showing relative symptoms, so that there is early detection of the virus as various different variants are still prevalent in Pakistan.

Aazar Ayaz of FINN Partners thanked the media for participating in the roundtable, in his closing remarks he said that this is going to help in disseminating knowledge and facts about clinical trials and will also create awareness among the media and through them in the general public about the importance of clinical trials. Clinical studies are essential for identifying additional approaches to protect our communities against major health threats. The participation of thousands of people in clinical studies was a key factor in the safe and efficient development of vaccines and medicines, as studies strictly adhered to international research ethics protocols.